Even though the results of the present study are heterogeneous, the possible mechanism may be that binding of peptides in these HLA molecules leads to an immune response, resulting in that HLA-B*40 allele seems to be a susceptibility biomarker in the development of ALL and probably a protecting biomarker in the development of AML. The gene discussed is HLA-B; the disease is acute myeloid leukemia.